138 related articles for article (PubMed ID: 9711796)
1. Coenzyme Q10 in vesicles composed of archaeal ether lipids or conventional lipids enhances the immuno-adjuvanticity to encapsulated protein.
Makabi-Panzu B; Sprott GD; Patel GB
Vaccine; 1998 Oct; 16(16):1504-10. PubMed ID: 9711796
[TBL] [Abstract][Full Text] [Related]
2. Influence of coenzyme Q10 on tissue distribution of archaeosomes, and pegylated archaeosomes, administered to mice by oral and intravenous routes.
Omri A; Makabi-Panzu B; Agnew BJ; Sprott GD; Patel GB
J Drug Target; 2000; 7(5):383-92. PubMed ID: 10721800
[TBL] [Abstract][Full Text] [Related]
3. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.
Patel GB; Sprott GD
Crit Rev Biotechnol; 1999; 19(4):317-57. PubMed ID: 10723627
[TBL] [Abstract][Full Text] [Related]
4. A structural comparison of the total polar lipids from the human archaea Methanobrevibacter smithii and Methanosphaera stadtmanae and its relevance to the adjuvant activities of their liposomes.
Sprott GD; Brisson J; Dicaire CJ; Pelletier AK; Deschatelets LA; Krishnan L; Patel GB
Biochim Biophys Acta; 1999 Sep; 1440(2-3):275-88. PubMed ID: 10521711
[TBL] [Abstract][Full Text] [Related]
5. Safety of archaeosome adjuvants evaluated in a mouse model.
Patel GB; Omri A; Deschatelets L; Sprott GD
J Liposome Res; 2002 Nov; 12(4):353-72. PubMed ID: 12519630
[TBL] [Abstract][Full Text] [Related]
6. TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10.
Shao Y; Yang L; Han HK
Eur J Pharm Biopharm; 2015 Jan; 89():339-46. PubMed ID: 25542680
[TBL] [Abstract][Full Text] [Related]
7. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
8. Archaeosomes made of Halorubrum tebenquichense total polar lipids: a new source of adjuvancy.
Gonzalez RO; Higa LH; Cutrullis RA; Bilen M; Morelli I; Roncaglia DI; Corral RS; Morilla MJ; Petray PB; Romero EL
BMC Biotechnol; 2009 Aug; 9():71. PubMed ID: 19678953
[TBL] [Abstract][Full Text] [Related]
9. Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity.
McCluskie MJ; Deschatelets L; Krishnan L
Hum Vaccin Immunother; 2017 Dec; 13(12):2772-2779. PubMed ID: 28537465
[TBL] [Abstract][Full Text] [Related]
10. Archaeosome immunostimulatory vaccine delivery system.
Patel GB; Chen W
Curr Drug Deliv; 2005 Oct; 2(4):407-21. PubMed ID: 16305444
[TBL] [Abstract][Full Text] [Related]
11. Preparation, in vitro Characterization and Pharmacokinetic Study of Coenzyme Q10 Long-Circulating Liposomes.
Yang S
Drug Res (Stuttg); 2018 May; 68(5):270-279. PubMed ID: 29190857
[TBL] [Abstract][Full Text] [Related]
12. New generation of liposomes called archaeosomes based on natural or synthetic archaeal lipids as innovative formulations for drug delivery.
Benvegnu T; Lemiègre L; Cammas-Marion S
Recent Pat Drug Deliv Formul; 2009 Nov; 3(3):206-20. PubMed ID: 19534669
[TBL] [Abstract][Full Text] [Related]
13. An increased adjuvanticity of liposomes by the inclusion of phosphatidylserine in immunization with surface-coupled liposomal antigen.
Mori M; Nishida M; Maekawa N; Yamamura H; Tanaka Y; Kasai M; Taneichi M; Uchida T
Int Arch Allergy Immunol; 2005 Jan; 136(1):83-9. PubMed ID: 15591816
[TBL] [Abstract][Full Text] [Related]
14. Systematically optimized coenzyme q10-loaded novel proniosomal formulation for treatment of photo-induced aging in mice: characterization, biocompatibility studies, biochemical estimations and anti-aging evaluation.
Yadav NK; Nanda S; Sharma G; Katare OP
J Drug Target; 2016; 24(3):257-71. PubMed ID: 26302815
[TBL] [Abstract][Full Text] [Related]
15. Archaeosomes as novel antigen delivery systems.
Sprott GD; Tolson DL; Patel GB
FEMS Microbiol Lett; 1997 Sep; 154(1):17-22. PubMed ID: 9297816
[TBL] [Abstract][Full Text] [Related]
16. Packaging of the Coenzyme Q
Yamada Y; Burger L; Kawamura E; Harashima H
Biol Pharm Bull; 2017; 40(12):2183-2190. PubMed ID: 29199241
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of archaeosome vehicles for transdermal vaccine delivery.
Jia Y; McCluskie MJ; Zhang D; Monette R; Iqbal U; Moreno M; Sauvageau J; Williams D; Deschatelets L; Jakubek ZJ; Krishnan L
J Liposome Res; 2018 Dec; 28(4):305-314. PubMed ID: 28948854
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.
Jia Y; Akache B; Deschatelets L; Qian H; Dudani R; Harrison BA; Stark FC; Chandan V; Jamshidi MP; Krishnan L; McCluskie MJ
Int J Pharm; 2019 Apr; 561():187-196. PubMed ID: 30836154
[TBL] [Abstract][Full Text] [Related]
19. Optimization in the preparation of coenzyme Q10 nanoliposomes.
Xia S; Xu S; Zhang X
J Agric Food Chem; 2006 Aug; 54(17):6358-66. PubMed ID: 16910731
[TBL] [Abstract][Full Text] [Related]
20. The advantages of a novel CoQ10 delivery system in skin photo-protection.
Yue Y; Zhou H; Liu G; Li Y; Yan Z; Duan M
Int J Pharm; 2010 Jun; 392(1-2):57-63. PubMed ID: 20302925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]